Eledon Pharmaceuticals Inc. (NASDAQ: ELDN) stock closed at 1.21 per share at the end of the most recent trading day (a -1.63% change compared to the prior day closing price) with a volume of 30.53K shares and market capitalization of 28.49M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 10 people. Eledon Pharmaceuticals Inc. CEO is David-Alexandre C. Gros.

The one-year performance of Eledon Pharmaceuticals Inc. stock is -59.27%, while year-to-date (YTD) performance is -46.93%. ELDN stock has a five-year performance of %. Its 52-week range is between 1.08 and 3.7, which gives ELDN stock a 52-week price range ratio of 4.96%

Eledon Pharmaceuticals Inc. currently has a PE ratio of -1.10, a price-to-book (PB) ratio of 0.28, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of -, a ROA of -25.62%, a ROC of -24.54% and a ROE of -26.87%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Eledon Pharmaceuticals Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.36 for the next earnings report. Eledon Pharmaceuticals Inc.’s next earnings report date is 13th Nov 2023.

The consensus rating of Wall Street analysts for Eledon Pharmaceuticals Inc. is Strong Buy (1), with a target price of $25.4, which is +1 999.17% compared to the current price. The earnings rating for Eledon Pharmaceuticals Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Eledon Pharmaceuticals Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Eledon Pharmaceuticals Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 26.51, ATR14 : 0.13, CCI20 : -73.26, Chaikin Money Flow : -0.18, MACD : -0.05, Money Flow Index : 43.20, ROC : -3.97, RSI : 43.27, STOCH (14,3) : 16.95, STOCH RSI : 0.78, UO : 43.13, Williams %R : -83.05), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Eledon Pharmaceuticals Inc. in the last 12-months were: Steven N. Perrin (Buy at a value of $2 597)